全文获取类型
收费全文 | 2702篇 |
免费 | 22篇 |
国内免费 | 2篇 |
专业分类
电工技术 | 16篇 |
综合类 | 1篇 |
化学工业 | 147篇 |
金属工艺 | 14篇 |
机械仪表 | 39篇 |
建筑科学 | 63篇 |
矿业工程 | 13篇 |
能源动力 | 45篇 |
轻工业 | 107篇 |
水利工程 | 7篇 |
无线电 | 78篇 |
一般工业技术 | 134篇 |
冶金工业 | 1931篇 |
原子能技术 | 6篇 |
自动化技术 | 125篇 |
出版年
2022年 | 8篇 |
2021年 | 8篇 |
2019年 | 10篇 |
2018年 | 15篇 |
2017年 | 13篇 |
2016年 | 13篇 |
2014年 | 16篇 |
2013年 | 44篇 |
2012年 | 24篇 |
2011年 | 33篇 |
2010年 | 15篇 |
2009年 | 23篇 |
2008年 | 24篇 |
2007年 | 39篇 |
2006年 | 28篇 |
2005年 | 32篇 |
2004年 | 25篇 |
2003年 | 24篇 |
2002年 | 17篇 |
2001年 | 19篇 |
2000年 | 15篇 |
1999年 | 71篇 |
1998年 | 551篇 |
1997年 | 339篇 |
1996年 | 228篇 |
1995年 | 127篇 |
1994年 | 108篇 |
1993年 | 137篇 |
1992年 | 30篇 |
1991年 | 41篇 |
1990年 | 46篇 |
1989年 | 24篇 |
1988年 | 29篇 |
1987年 | 29篇 |
1986年 | 36篇 |
1985年 | 40篇 |
1984年 | 19篇 |
1983年 | 24篇 |
1982年 | 22篇 |
1981年 | 22篇 |
1980年 | 36篇 |
1979年 | 13篇 |
1978年 | 13篇 |
1977年 | 69篇 |
1976年 | 107篇 |
1975年 | 14篇 |
1974年 | 12篇 |
1973年 | 12篇 |
1972年 | 7篇 |
1968年 | 6篇 |
排序方式: 共有2726条查询结果,搜索用时 171 毫秒
991.
In this report, we describe a strategy for enhancing the immunogenicity of a wide variety of Ags by linking them to IL-2 via an IgG3-IL-2 fusion protein with high affinity for a convenient hapten Ag, dansyl (DNS; N,N-dimethyl-1-aminonaphthalene-5-sulfonyl chloride). This fusion protein, anti-DNS-IgG3-IL-2, combines the functional characteristics of its constituents and has pharmacokinetic properties that are greatly improved over those of IL-2 and a previously described IgG1-IL-2 fusion. The molecule is intact and recoverable from the blood of mice hours after i.p. injection and reaches distant organs throughout the animal. The 7-h in vivo half-life of this molecule is much longer than that of IL-2, addressing a major obstacle in the application of IL-2 to human diseases, including cancer and AIDS. Additionally, the Ab's specificity for the hapten dansyl and the convenient chemistry of dansyl provide a means to link IL-2 to virtually any molecule of interest without the complexities and uncertainties of making IL-2 fusions with each molecule individually. Using hapten-conjugated-BSA (DNS-BSA) as a model Ag we show that the Ab response elicited by anti-DNS-IgG3-IL-2-bound DNS-BSA-Sepharose injected into mice is increased over that of DNS-BSA-Sepharose or anti-DNS-IgG3-bound DNS-BSA-Sepharose. Anti-DNS-IgG3-IL-2 also increased the Ab response to soluble DNS-BSA after a booster injection. This system should be useful in testing the ability of IL-2 to potentiate the immune response to Ag and in screening a large number of potential Ags for use in vaccines. The dramatically improved pharmacokinetics should also overcome one of the major difficulties in applying IL-2 to the treatment of human disease, its short half-life. 相似文献
992.
AJ Nichols JA Vasko PF Koster RE Valocik GR Rhodes C Miller-Stein V Boppana JM Samanen 《Canadian Metallurgical Quarterly》1994,270(2):614-621
The in vivo pharmacological profile of SK&F 106760 [N alpha-acetyl-cyclo(S,S)-cysteinyl-N alpha-methylarginyl-glycyl-aspartyl-penicillamine-amide], a novel, potent glycoprotein IIb/IIIa (GPIIb/IIIa) antagonist has been investigated. In conscious dogs, SK&F 106760 (0.3-3 mg/kg i.v.) produced a dose-related inhibition of ex vivo whole blood platelet aggregation induced by collagen (5 micrograms/ml) with complete inhibition being produced for 5, 90 and 165 min after administration of 0.3, 1 and 3 mg/kg i.v., respectively. Plasma levels of SK&F 106760 were measured by high-performance liquid chromatography after i.v. bolus administration of 1 mg/kg. An initial alpha-disposition phase with a T1/2 of 11 +/- 6 min was followed by a longer terminal beta-elimination phase with a T1/2 of 66 +/- 12 min, which accounted for 79 +/- 9% of the total area under the plasma concentration-time curve. The apparent steady-state volume of distribution was 259 +/- 26 ml/kg and the plasma clearance was 3.4 +/- 0.8 ml/min/kg. The plasma concentration of SK&F 106760 at which collagen-induced ex vivo whole blood aggregation was inhibited by 50% was estimated to be 593 +/- 52 nM. After intraduodenal and intrajejunal administration of 3 mg/kg, SK&F 106760 had a bioavailability of 3 to 6% and produced a peak inhibition of ex vivo platelet aggregation of 40 to 50%. In anesthetized dogs, SK&F 106760 (0.3-3.0 mg/kg i.v.) produced a complete inhibition of platelet-dependent coronary artery thrombosis, with a dose-related duration of action.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
993.
GR Jones 《Canadian Metallurgical Quarterly》1996,347(9006):968-969
994.
1. The pharmacokinetics, tissue distribution and excretion of the nitrofuran drug furazolidone have been examined in the channel catfish. [14C]Furazolidone was administered by intravascular or oral routes in a single dosage of 1 mg/kg body weight. 2. A two-compartment pharmacokinetic model best described parent furazolidone concentrations in the plasma after intravascular dosing. Elimination of parent compound was extremely rapid, with a terminal half-life of 0.27h and total body clearance of 1901 ml/h/kg. 3. After oral dosing, furazolidone concentrations in the plasma were highest at 1 h and were below the limit of determination (< 20 ng/ml) at 5 h. The oral bioavailability of parent furazolidone administered in solution was 58%, compared with 28% in a feed mixture. 4. Concentrations of furazolidone and its metabolites were highest in the excretory tissues and lowest in the muscle after oral dosing. Parent furazolidone comprised 10% of the total 14C in the muscle at 8 h and was not detectable (< 1 ng/g) at 24 h; total 14C concentrations declined from 274 to 59 ng furazolidone equiv./g between 8 and 168 h. Non-extractable (bound) residues comprised 18% of total 14C in muscle at 8 h and 33% at 168h. 5. Renal excretion was the primary route of elimination of 14C residues and accounted for nearly 55% of the oral dose. 相似文献
995.
SM Walpole A Nicolaou GR Howell A Whittaker DR Bentley MT Ross JR Yates D Trump 《Canadian Metallurgical Quarterly》1997,44(3):300-308
Treatment of a skeletodental Class II vertical growth problem, combined with a severe arch length deficiency in both arches, presents a challenging orthodontic problem. This is the case report of a small-statured, 11-year, 10-month-old boy with a history of juvenile chronic arthritis and marked mandibular retrognathia who was treated with first premolar extractions in both arches. Unexpected favorable growth, with significant decrease of the mandibular plane angle over a long treatment period, provided a very satisfactory result. [This case report was presented to the American Board of Orthodontics in partial fulfillment of the requirements for the certification process.] 相似文献
996.
Fibromyalgia is a complex condition affecting up to six million patients. In this literature review, the prevalence, proposed etiology, differential diagnosis, and signs and symptoms of the disorder are presented. Diagnostic criteria, treatment options, and the importance of patient education are explored. 相似文献
997.
GR Lipscomb N Wallis G Armstrong MJ Goodman WD Rees 《Canadian Metallurgical Quarterly》1996,41(8):1583-1588
Our objective was to determine whether H. pylori influences gastric mucosal injury and adaptation caused by naproxen. Twenty-four healthy volunteers, 12 H. pylori-positive and 12 H. pylori-negative, were given a 28-day course of naproxen 500 mg twice a day. They were each gastroscoped to assess gastric mucosal damage and mucosal blood flow before and at 1, 7, and 28 days during treatment. Maximal gastric mucosal damage (median grade + IQR) occurred during the first 24 hr in both groups and was of similar magnitude (H. pylori-positive: 2.5, 2.0-3.0 P < 0.01; H. pylori-negative: 2.0, 1.0-3.0 P < 0.01). This damage was associated with a fall in antral but not corpus mucosal blood flow. With continued NSAID administration, gastric damage resolved confirming adaptation (H. pylori-positive 1.0, 0-2.0, H. pylori-negative: 1.0, 0-1.0) and antral mucosal blood flow returned to baseline in both groups by day 28. These observations suggest that initial gastric mucosal injury is not influenced by H. pylori colonization and adaptation occurs regardless of its presence. 相似文献
998.
WA Zatonski AB Lowenfels P Boyle P Maisonneuve HB Bueno de Mesquita P Ghadirian M Jain K Przewozniak P Baghurst CJ Moerman A Simard GR Howe AJ McMichael CC Hsieh AM Walker 《Canadian Metallurgical Quarterly》1997,89(15):1132-1138
BACKGROUND: There are few previous epidemiologic studies of gallbladder cancer, a rare but nearly always lethal gastrointestinal cancer with a demonstrated greater frequency in adult women and older subjects of both sexes, and also in the members of populations throughout central and eastern Europe and certain racial groups such as native American Indians. Unfortunately, the prospects for the prevention of this form of cancer are poor. PURPOSE: Our purpose in conducting this study was to investigate possible new risk factors for gallbladder cancer and to strengthen our understanding of established causal agents that may be involved in this disease. METHODS: A large, collaborative, multicenter, case-control study of cancer of the gallbladder was conducted in five centers located in Australia (Adelaide), Canada (Montreal and Toronto), The Netherlands (Utrecht), and Poland (Opole) from January 1983 through July 1988. Case subjects with gallbladder cancer were accrued by the centers from hospital pathology records and from reports to regional cancer registries. Cancer diagnosis was confirmed by either biopsy, cholecystectomy, or at the time of autopsy. Control subjects were randomly assigned at each center from the population. The pooled analysis included 196 case subjects and 1515 control subjects (who did not report previous cholecystectomy). Ninety-eight percent of the subjects were white. Personal interviews of case subjects, control subjects, and surrogates (spouse or next of kin) were conducted by trained personnel. RESULTS: After adjusting for potential confounding factors (age, sex, center, type of interview, years of schooling, alcohol intake, and lifetime cigarette smoking), a history of gallbladder symptoms requiring medical attention (e.g., reduced bile secretion from the gallbladder into the small intestine due to obstructions of the common bile or cystic ducts) was the major risk factor associated with this form of cancer (odds ratio [OR] = 4.4; 95% confidence interval [CI] = 2.6-7.5). This association was present even in subjects who had their first gallbladder examination because of symptoms present more than 20 years earlier (OR = 6.2; 95% CI = 2.8-13.4). Other variables associated with gallbladder cancer risk included an elevated body mass index, high total energy intake, high carbohydrate intake (after adjustment for total energy intake), and chronic diarrhea. All of these risk factors have been previously associated with gallstone disease. CONCLUSIONS: These findings are consistent with a major role of gallstones, or risk factors for gallstones, in the cause of gallbladder cancer. Additional information on whether or not screening high-risk subjects for gallstones or gallbladder cancer is needed. 相似文献
999.
1000.